Phio Pharmaceuticals Announces Positive Recommendation From Safety Monitoring Committee of Phase 1B Clinical Study of Phio S Lead Compound Ph-762
Phio Pharmaceuticals 宣佈安全監測委員會對 Phio S 先導化合物 Ph-762 的 1B 期臨床研究提出積極建議
Phio Pharmaceuticals Announces Positive Recommendation From Safety Monitoring Committee of Phase 1B Clinical Study of Phio S Lead Compound Ph-762
Phio Pharmaceuticals 宣佈安全監測委員會對 Phio S 先導化合物 Ph-762 的 1B 期臨床研究提出積極建議
譯文內容由第三人軟體翻譯。